Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$11.75 - $21.42 $146,158 - $266,443
-12,439 Closed
0 $0
Q3 2018

Oct 09, 2018

SELL
$19.26 - $23.46 $18,547 - $22,591
-963 Reduced 7.19%
12,439 $267,000
Q2 2018

Jul 11, 2018

SELL
$19.78 - $24.67 $42,962 - $53,583
-2,172 Reduced 13.95%
13,402 $277,000
Q1 2018

Apr 17, 2018

SELL
$18.89 - $32.46 $4,344 - $7,465
-230 Reduced 1.46%
15,574 $392,000
Q4 2017

Jan 16, 2018

BUY
$16.19 - $20.3 $922 - $1,157
57 Added 0.36%
15,804 $300,000
Q3 2017

Oct 12, 2017

BUY
$15.52 - $18.94 $244,393 - $298,248
15,747
15,747 $291,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $200M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.